Docetaxel–carboplatin chemotherapy combined with cetuximab in patients with locally advanced or metastatic non small-cell lung cancer (NSCLC)—Results of the nonrandomised phase II study TaxErb-Reference-Cited by-同舟云学术

Docetaxel–carboplatin chemotherapy combined with cetuximab in patients with locally advanced or metastatic non small-cell lung cancer (NSCLC)—Results of the nonrandomised phase II study TaxErb

Published:2012-03 Issue:3 Volume:75 Page:348-352
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Fischer J.R.,Griesinger F.,Fink T.,Salm T.,Marseille A.,Wolf M.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference46 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. American society of clinical oncology clinical practice guideline update on chemotherapy for stage IV non-small cell lung cancer;Azzoli;J Clin Oncol,2009

3. Prävention, diagnostik therapie und nachsorge des lungenkarzinoms;Goeckenjan;Pneumologie,2010

4. Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy;Herbst;Cancer,2002

5. Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small cell lung cancer;Khambata-Ford;J Clin Oncol,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis;Cancer Treatment Reviews;2019-01

2. Formulations, Pharmacodynamic and Clinical Studies of Nanoparticles for Lung Cancer Therapy - An Overview;Current Drug Metabolism;2018-08-29

3. Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer;Lung Cancer;2013-09

4. Targeted therapies in non-small cell lung carcinoma: what have we achieved so far?;Therapeutic Advances in Medical Oncology;2013-06-13

5. Lung cancer and genitourinary cancers;Monoclonal Antibodies Targeting EGFR/HER2 and Clinical Outcomes in Cancer Treatment;2013-06